The results showed that DNA methylation sites cg13892570 and cg16107628 significantly downregulated TAGLN2 expression (β = −0.53 and −0.61, P < .05), indirectly reducing the risk of PAH. Here, TAGLN2 is linked to pulmonary arterial hypertension.